Repare Therapeutics Eulerpool News

Repare Therapeutics Notizie Azioni

Repare Therapeutics è seguito da molti giornalisti e investitori in tutto il mondo. Qui raccogliamo le più recenti notizie Repare Therapeutics.

• 12 novembre ·

  Yahoo
  Repare Therapeutics Announces Agreement with the US National Cancer Institute to Advance the Development of Camonsertib
• 7 novembre ·

  Yahoo
  Repare Therapeutics Provides Business and Clinical Update and Reports Third Quarter 2024 Financial Results
• 24 ottobre ·

  TipRanks
  Repare Therapeutics Receives Buy Rating Due to Improved Treatment Tolerability and Promising Clinical Outcomes
• 24 ottobre ·

  Yahoo
  Repare Therapeutics’ individualised anaemia management trial shows promise
• 24 ottobre ·

  TipRanks
  TD Cowen Sticks to Its Buy Rating for Repare Therapeutics (RPTX)
• 23 ottobre ·

  Yahoo
  Repare Therapeutics Announces Updated Positive Safety and Tolerability Results from the Phase 1 MYTHIC Clinical Trial
• 23 ottobre ·

  Thefly.com
  Repare Therapeutics presents data from Phase 1 MYTHIC clinical trial
• 15 ottobre ·

  Yahoo
  RPTX Stock Up as Dosing Begins in Solid Tumor Study for Combo Drug
• 14 ottobre ·

  Yahoo
  Repare Therapeutics Doses First Patient in Phase 1 Clinical Trial of RP-3467, a Polθ ATPase Inhibitor
• 14 ottobre ·

  Thefly.com
  Repare Therapeutics doses first patient in POLAR trial